| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10454773 | Brain, Behavior, and Immunity | 2013 | 9 Pages |
Abstract
⺠Patients undergoing primary treatment for ovarian cancer experience reductions in inflammation and improvements in fatigue, vegetative depression and disability.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Andrew Schrepf, Lauren Clevenger, Desire Christensen, Koen DeGeest, David Bender, Amina Ahmed, Michael J. Goodheart, Laila Dahmoush, Frank Penedo, Joseph A. III, Parvin Ganjei-Azar, Luis Mendez, Kristian Markon, David M. Lubaroff, Premal H. Thaker,